Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Reexamination Certificate
2011-08-09
2011-08-09
Swartz, Rodney P. (Department: 1645)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
C424S184100, C424S185100, C424S234100, C435S004000, C435S007100, C435S007200, C435S029000, C530S300000, C530S350000
Reexamination Certificate
active
07993657
ABSTRACT:
Serum antibody assays capable of distinguishing cases of inactive TB from cases of active TB include a combination of at least threeM. tuberculosisprotein antigens, at least one for which a positive response is consistent with inactive TB and at least one for which a negative response is consistent with inactive TB. Preferred assays further distinguish other TB classes. Also, antigen kits for performing such assays.
REFERENCES:
patent: 4016043 (1977-04-01), Schuurs et al.
patent: 6087163 (2000-07-01), Gennaro et al.
patent: 6506384 (2003-01-01), Zolla-Pazner et al.
patent: 6596281 (2003-07-01), Gennaro et al.
patent: 2003/0143652 (2003-07-01), Simonson
patent: 2005/0089904 (2005-04-01), Beaulieu et al.
patent: 0011214 (2000-03-01), None
patent: PCT/US00/12197 (2000-11-01), None
patent: PCT/US00/12257 (2000-11-01), None
patent: 0179274 (2001-10-01), None
patent: WO2005/080990 (2005-09-01), None
Cole, S.T, et al, Nature, vol. 396, Nov. 12, 1998, pp. 190-198.
Cole, S.T., et al, Nature, vol. 393, Jun. 11, 1998, pp. 537-543.
Mustafa, A.S., Molecular Immunology, vol. 39, pp. 113-119, 2002.
American Thoracic Society, Diagnostic Standards and Classification of Tuberculosis in Adults and Children. Am. J. Respir. Crit. Care Med. 161:1376-95. 2000.
Bifani, P.J. et al., Global Dissemination of theMycobacterium tuberculosisW-Beijing Family Strains. Trends Microbiol. 10:45-52. 2002.
Bothamley, G.H., Serological Diagnosis of Tuberculosis. Eur. Respir. J. 8, suppl. 20:676s-688s. 1995.
Bothamley, G.H. et al., Specificity of Antibodies and Tuberculin Response After Occupational Exposure to Tuberculosis. J. Infect. Dis. 166:182-6. 1992.
Colangeli, R. et al., Three-step purification of lipopolysaccharide-free, polyhistidine-tagged recombinant antigens ofMycobacterium tuberculosis. J. Chromatogr. B. 714:223-235. 1998.
Grzybowksi, S. et al., Reactivation in inactive pulmonary tuberculosis. Am. Rev. Resp. Dis. 93:352-360. 1966.
Grzybowski, S. et al., Tuberculosis among patients with various radiologic abnormalities, followed by the chest clinic service. Am. Rev. Resp. Dis. 104:605-608. 1971.
Harboe, M. The 38-kDa protein ofMycobacterium tuberculosis: a review. J. Infect. Dis. 166:874-884. 1992.
Harth, G. Glutamine synthetase ofMycobacterium tuberculosis: extracellular release and characterization of its enzymatic activity. Proc. Natl. Acad. Sci. U.S.A. 91:9342-6. 1994.
Honer Zu Bentrup, K. and D.G. Russell, Mycobacterial persistence: adaptation to a changing environment. Trends Microbiol 9:597-605. 2001.
Hutter, B. and M. Singh, Properties of the 40 kDa antigen ofMycobacterium tuberculosis, a functional L-alanine dehydrogenase. Biochem. J. 343 Pt 3:669-72. 1999.
Kaplan, M.H. and M.W. Chase, Antibodies to mycobacteria in human tuberculosis. I. Development of antibodies before and after antimicrobial therapy. J. Infect. Dis. 142:825-34. 1980.
Manca, C.L. et al.,Mycobacterium tuberculosisCDC1551 induces a more vigorous host response in vivo and in vitro, but is not more virulent than other clinical isolates. J. Immunol. 162:6740-6. 1999.
McKinney, J.D. et al., Persistence ofMycobacterium tuberculosisin macrophages and mice requires the glyoxylate shunt enzyme isocitrate lyase. Nature 406:735-8. 2000.
Monack, D.M. et al., Persistent bacterial infections: the interface of the pathogen and the host immune system. Nat. Rev. Microbiol. 2:747-65. 2004.
Nolan, C. and E. Am, Tuberculosis in a cohort of Southeast Asian refugees. Am. Rev. Resp. Dis. 137:805-809. 1988.
Segal, W., Growth dynamics of in vivo and in vitro grown mycobacterial pathogens, p. 547-573, In G.P. Kubica and L. G. Wayne (ed.), The Mycobacteria. A Sourcebook. Marcel Dekker, Inc., New York. 1984.
Sherman, D.R. et al., Regulation of theMycobacterium tuberculosishypoxic repsonse gene encoding alpha-crystallin. Proc. Natl. Acad. Sci. U.S.A. 98:7534-9. 2001.
Shi, L. et al., Expression of Th1-mediated immunity in mouse lungs induces aMycobacterium tuberculosistranscription pattern characteristic of nonreplicating persistence. Proc. Natl. Acad. Sci. U.S.A. 100:241-6. 2003.
Shi, L. et al., Effect of growth state on transcription levels of genes encoding major secreted antigens ofMycobacterium tuberculosisin mouse lung. Infect. Immun. 72:2420-2424. 2004.
Intentionally omitted.
Sorensen, A.L. et al., Purification and characterization of a low-molecular-mass T-cell antigen secreted byMycobacterium tuberculosis. Infect. Immun. 63: 1710-1717. 1995.
Stewart, G.R. et al., Tuberculosis: a problem with persistence. Nat. Rev. Microbiol. 1:97-105. 2003.
Turneer, M. et al., Humoral immune response in human tuberculosis: immunoglobulins G, A, and M directed against the purified P32 protein antigen ofMycobacterium bovisbacillum Calmette-Guerin. J. Clin. Microbiol. 26: 1714-9. 1988.
Voskuil, M.I. et al., Inhibition of respiration by nitric oxide induces aMycobacterium tuberculosisdormancy program. J. Exp. Med. 198:705-13. 2003.
Wayne, L.G., Dormancy ofMycobacterium tuberculosisand latency of disease. Eur. J. Clin. Microbiol. Infect. Dis. 13:908-14. 1994.
Weber, I. et al., Anaerobic nitrate reductase (narGHJI) activity ofMycobacterium bovisBCG in vitro and its contribution to virulence in immunodeficient mice. Mol. Microbiol. 35:1017-25. 2000.
Wilkins, E.G.L., The serodiagnosis of tuberculosis, p. 367-380, in P.D.O. Davies (ed.), Clinical tuberculosis. Chapman and Hall Medical, London. 1994.
Wilkinson, R.J. et al., Human T- and B-cell reactivity to the 16kDa alpha-crystallin protein ofMycobacterium tuberculosis. Scand. J. Immunol. 48:403-9. 1998.
Zhang, Y. et al., Genetic analysis of superoxide dismutase, the 23 kilodalton antigen ofMycobacterium tuberculosis. Mol. Microbiol. 5:381-391. 1991.
Zuber, P. et al., Long-term risk of tuberculosis among foreign-born persons in the United States. JAMA 278:304-307. 1997.
Cole, S.T., et al., “Deciphering the Biology ofMycobacterium tuberculosisfrom the Complete Genome Sequence,” Nature, vol. 393, Jun. 11, 1998, p. 537-544.
Cole, S.T., et al., “Deciphering the Biology ofMycobacterium tuberculosisfrom the Complete Genome Sequence,” Nature, vol. 396, Nov. 12, 1998.
Extended European Search Report dated Mar. 3, 2010, received in connection with EP Application No. 06788711.7.
A. Davidow et al, “Antibody profiles characteristic ofMycobacterium tuberculosisinfection state,” Infection and Immunity, vol. 73, No. 10, pp. 6846-6851 (Oct. 2005).
D. Vincenti et al., “Identification of early secretory antigen target-6 epitopes for the immunodiagnosis of active tuberculosis,” Molecular Medicine, vol. 9, No. 3/4, pp. 105-111 (Mar./Apr. 2003).
Silva et al., “Factors associates with humoral response to ESAT-6, 38 kDa and 15 kDa in patients with a spectrum of tuberculosis”, Int. J. Tuberc. Lung Dis, 7(5):478-484 (2003).
Lowenstein & Sandler PC
Swartz Rodney P.
University of Medicine and Dentistry of New Jersey
LandOfFree
Antibody profiles characteristic of tuberculosis state does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Antibody profiles characteristic of tuberculosis state, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antibody profiles characteristic of tuberculosis state will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2643457